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Abstract
A detailed account of the construction, properties, and practical applications of 
electrospinning for the fabrication of high-quality ultrafine fibers, suitable for drug 
delivery, is given. With respect to the electrospinning method, various parameters 
are of crucial importance. The electrospinning parameters are classified as solution 
properties, process parameters, and environmental conditions. The solution prop-
erties include the polymer concentration, molecular weight and viscosity, the solu-
tion conductivity and relative volatility, volatility of the solvent, surface tension, 
and dielectric constant. The process parameters refer to the flow rate, the applied 
voltage, the needle diameter, and the distance between the tip of the needle and col-
lector and the geometry of the collector. The environmental conditions include the 
relative humidity and temperature. All these factors are responsible for a flawless 
electrospinning process, which leads to the formation of the desirable electrospun 
nanofibers with the requisite characteristics. In this chapter, it has been shown that 
the electrospinning technology could provide a useful method for modifying drug 
release behavior and opens new routes for the development of effective and tailor-
made drug release carriers.
Keywords: nanofibers, electrospinning, electrospinning parameters, polymers,  
oral drug delivery
1. Introduction
During the last years, nanofibers have become increasingly attractive as drug 
delivery systems, mainly because they enhance the delivery of limited absorp-
tion drugs by improving the dissolution rates and solubility of drug molecules. 
Moreover, nanofibrous approaches in preparing stable amorphous drug formula-
tions are extensively profitable [1].
The principal methods used for the fabrication of polymer nanofibers include 
drawing, template synthesis, phase separation, self-assembly, solvent casting, and 
electrospinning. However, the latter has become the most frequently used technique 
because of its ability to afford nanofibers with unique characteristics. These include 
a very high surface area to volume ratio, a high porosity with a small pore size, 
improved mechanical properties, degradability, and flexibility in surface function-
alities/motifs. All the other fabrication methods have limitations, with respect to 
the materials used, and moreover, they are laborious and complex processes, result-
ing in problematic scale-up. Furthermore, compared with the other processing 
techniques, electrospinning is a simple, user-friendly, reproducible, and continuous 
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process [1–4], and upon the appropriate selection of the electrospinning apparatus 
and materials, diverse types of fibers, such as core-sheath, porous or hollow struc-
tured nanofibers can be produced.
2. Electrospinning
As already mentioned, electrospinning is a simple, highly versatile and robust 
technique for the production of polymers and a wide range of materials, including 
ceramic, metallic, and long fibers with diameters from submicron down to nano-
meter scale. These fibers are produced by feeding a polymer solution, dispersion 
or melt in a high electric field. It is worth mentioning that the use of melt in the 
electrospinning process is costly and leads to more difficult production than using 
polymer solution [1–6].
2.1 Electrospinning equipment
The main setup of an electrospinning equipment involves three main parts all 
enclosed within a chamber. A typical electrospinning apparatus is shown in Figure 1.  
It is composed of an electrical supply, for generating a high-voltage power supply, a 
piece of feeding equipment, which consists of a glass syringe with metallic needle filled 
with the polymer solution, a pump suitable for controlling the flow rate of the polymer 
solution, and a grounded collector usually made from aluminum foil. The power 
supply is used to apply tens of kilovolt to the needle, which works as a spinneret, while 
the pump extrudes the polymer from the syringe to the collector, which can be either 
rotatable or static [2, 4, 5, 7–9].
2.2 Electrospinning process and methods
2.2.1 Electrospinning process
The working principle of electrospinning is straightforward: at ambient temper-
ature, a polymer solution or melt is ejected from the tip of a needle to a grounded 
metal collector by applying high voltage between the needle and the collector [2]. In 
Figure 1. 
Typical schematic setup of electrospinning equipment with static (up) and rotatable collector (down).
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detail, the electrospinning process starts with the application of high voltage, which 
creates electric charges that are moving toward the polymer solution in the syringe 
via the metallic needle. The induction of charges on the polymer droplet causes 
instability within the polymer solution, thus creating an electrically charged jet of 
polymer solution or melt. Concurrently, a force that opposes the surface tension is 
produced, by the mutual repulsion of charges, and as a result, the polymer solution 
flows in the direction of the electric field and is extruded from the needle of the 
syringe with the aid of a pump [4]. Specifically, the solution jet is ejected from the 
nozzle of the needle when the voltage exceeds a threshold value because the electric 
force overcomes the surface tension of the droplet. Each droplet is exposed to a high 
voltage, and a cone-shaped droplet is formed. This is known as the Taylor cone and 
is caused due to the electrical voltage, which is the difference voltage between the 
nozzle and the collector with the counter charge [8]. Subsequently, the charged 
jet of solution is evaporated or solidified before reaching the metallic collector, 
where the solid material is collected as a solid interconnected continuous network 
of small fibers [1, 8, 10]. Regarding the electrospinning process, a stable charge jet 
can be formed only if the polymer solution has adequate cohesive force. During the 
process, the internal and external charge forces cause the whipping of the liquid jet, 
thus permitting the polymer chains to stretch and slide into the solution pushing 
the jet toward the collector [4]. As a result, the created fibers have enough small 
diameters to be characterized as diversely functionalized nanofibers because of 
their surface structure and their potential to modify their morphology and their 
internal bulk content [1, 4, 11, 12].
2.2.2 Electrospinning methods
The electrospinning technique is very useful for the incorporation of drugs in 
drug delivery systems. This technique can be reproducible under controlled param-
eters and is used in many formulations for the creation of new and innovative drug 
carriers because of their efficiency of transporting the bioactive agents to the target 
without causing secondary effects in the body. There are different methods for 
incorporating therapeutic drugs into drug delivery systems with electrospinning, 
which can greatly influence the properties of the resulting drug-loaded fibrous 
system. These methods involve blending, coaxial, emulsion, and surface modifica-
tion electrospinning, which have discrete advantages and disadvantages. According 
to the physicochemical properties of the drug, the polymeric characteristics and the 
application of the drug-incorporated fibers, such as the target zone and the required 
drug release rate, the appropriate method is being selected as not all drugs can be 
loaded with all of these methods [3, 13, 14].
2.2.2.1 Blending electrospinning
Blending of the therapeutic agent with the appropriate polymeric solution 
remains the most predominant method for drug loading into nanofibers [3, 13]. 
This method is simple, compared to others, but some requirements should be met 
in order to gain the desired results. The polymeric blend improves the mechani-
cal and physicochemical properties equilibrium of the drug-loaded nanofibers 
and increases effectively the formulation design for drug release, resulting in the 
manipulation of the release rate by changing the proportion of polymer in the blend 
[3, 15]. The insufficient solubility of the drug in the polymeric solution, where 
the drug molecules can shift to a nearby surface of fiber during electrospinning, 
can trigger the isolate release of the drug into the solution. Thus, the equilibrium 
among hydrophilic and hydrophobic properties between drugs and polymers is 
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very important during blending electrospinning [3, 7]. The drug release behavior is 
highly contingent on the distribution of the drug molecule into electrospun nano-
fibers as well as on the morphology of the nanofibers. In order to achieve perfect 
encapsulation of the drug inside the electrospun nanofibers, the hydrophobic poly-
ester polymers should interact very well with the hydrophobic or lipophilic drugs, 
such as rifampicin and paclitaxel, while the hydrophilic polymers, such as gelatin, 
polyethylene glycol (PEG), and polyvinyl alcohol (PVA), can dissolve hydrophilic 
drugs, such as doxorubicin. It has been cited that amphiphilic copolymers like the 
PEG-b-PLA diblock copolymer could significantly enhance drug-loading efficiency 
and subsequently reduce the burst release of drugs [13]. With the blending electro-
spinning method, the drug is dissolved or dispersed into the polymer solution to 
achieve drug encapsulation through a single-step electrospinning, and as a result, 
fibers are obtained with single phase only [3, 13].
2.2.2.2 Coaxial electrospinning
The coaxial electrospinning method is regarded as one of the most significant 
breakthroughs, and it is mainly useful for multidrug delivery systems, where the 
individual drug release behavior is controlled [2, 3, 13]. In this method, there are 
two liquids inside the spinneret, which minimize the interaction between aqueous-
based biological molecules and the organic solvents, in which the polymer is mainly 
dissolved, and as a result is used for obtaining fibers with core-shell structures [2, 3, 13]. 
These structures are used in cases where the therapeutic agent is sensible to 
the environment [3]. Moreover, this method can be used for generating novel 
structural nanomaterials, such as preparing nanofibers from materials without 
filament-forming properties enclosing functional liquids within the fiber matrix 
and encapsulating drugs or biological agents in the core of the polymer nanofibers 
leading to sustained and controlled drug release [2, 3]. The functionality of biomol-
ecules is improved in coaxial electrospinning because the inner jet is formed by the 
biomolecule solution, and the outer jet is formed by the polymer solution, which is 
the co-electrospun. Moreover, the polymeric shell contributes to the sustained and 
prolonged release of the therapeutic agent as well as protecting the ingredient in 
the core from direct exposure to the biological environment [3, 13]. In this method, 
the coaxial fibers have successfully loaded proteins, growth factor, antibiotics, and 
other biological agents for drug delivery purposes [3, 13]. In coaxial electrospin-
ning, there are a lot of factors, which should be considered in the design step, such 
as shell and core polymer concentration, molecular weight, and drug concentration 
[13, 14]. Nevertheless, only a limited portion of the produced fibers can form the 
proper core/shell structure and this system improves the sustained release of drugs 
and allows the bioability of unstable biological agents to be maintained [3, 14].
2.2.2.3 Emulsion electrospinning
The emulsion electrospinning method is an important and flexible method for 
the encapsulation of several drugs into nanofibers as well as a cost-effective and 
efficient manner for preparing core-shell electrospun nanofibers [3, 14]. In the 
emulsion electrospinning method, the oil phase is created by the emulsion of the 
drug or aqueous protein solution in the hydrophobic polymer solution. At the end 
of the electrospinning, the biomolecule-loaded phase can be distributed within 
the fibers, if a low molecular weight drug is used, or a core-shell fibrous structure 
can be configured as macromolecules in the aqueous phase [3, 13, 14]. It has been 
reported that the ratio of hydrophilic (aqueous) to hydrophobic (polymer) solu-
tion is one of the parameters that affect the distribution of the biomolecules within 
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the fibers. Moreover, it plays an important role in regulating the release profile, 
structural stability, and bioactivity of the encapsulated drug or proteins [3, 13, 14]. 
It is worth mentioning that the main advantage of emulsion electrospinning against 
blending electrospinning is the elimination of the need for a common solvent as the 
drug and the polymer are dissolved in applicable solvents. Numerous hydrophilic 
drugs and hydrophobic polymeric combinations can be used while maintaining 
minimal drug contact with the organic solvent during the procedure [3, 13, 14, 16]. 
However, the emulsion electrospinning would still cause damage or degradation 
of unstable macromolecules, like nucleic acids, mainly because of the shearing 
force and tension between the two phases of the emulsion, compared to coaxial 
electrospinning. Therefore, further modifications, like condensation of the carrier 
gene in gene therapy might be useful for more protection. Furthermore, during 
the emulsification or ultrasonication procedures in emulsion electrospinning, the 
contact of core materials with the solvent is increased, which may cause probable 
damage to the drug contents. Although extremely hydrophobic polymers can be 
used in emulsion electrospinning, the affinity or compatibility between drug and 
polymer might also influence the distribution of drugs within the fibers. It is cited 
that the copolymerization of hydrophobic polymers with hydrophilic polymers, 
such as PEG, ε-caprolactone (6-hexanolactone) (PCL), and poly(3-hydroxybutyric 
acid-co-3-hydroxyvaleric acid) (PHBV), affects drug distribution [3, 13, 14].
2.2.2.4 Surface modification electrospinning
The surface modification electrospinning is another promising method for 
introducing biofunctionality into nanofibers. In the surface modification elec-
trospinning, a specific conductive surface can be chemically altered and changed 
aiming at modifying the external properties of a coated device, such as the tissue, 
which encircles the implanted material [3]. In this strategy, the release of the thera-
peutics is weakened and the functionality of the surface, where the immobilized 
biomolecules are located, preserved [13, 17]. Thus, this method is applied to avoid 
fast initial burst release and to slow down the rate of immobilization of the biologi-
cal molecules on a particular surface. Therefore, the surface modification elec-
trospinning is more applicable for gene or growth-factor delivery where slow and 
prolonged release of the therapeutic agent is required [13, 17]. Moreover, having a 
good electrospinning system and a well-standardized method, it is possible to coat 
3D surfaces with nanoparticles or homogeneous surfaces [3, 16]. In cases where the 
drug cannot be immobilized, either because the drug is required to be endocytosed 
or interact with the nucleus of the cell, its release rate could be accurately controlled 
by introducing responsive materials to local external cues. This can happen by 
introducing hydrophobic functional groups onto the nanofibers surface [13].
2.3 Electrospinning parameters
The fabrication of nanofibers via electrospinning is affected by many different, 
but interlinked parameters as shown in Table 1 [1]. These parameters modulate 
both the electrospinning process and the morphology of nanofibers [1, 4]. The 
electrospinning parameters can be classified as solution properties, process param-
eters, and environmental conditions [1, 4, 8]. The solution properties include the 
polymer concentration, molecular weight and viscosity, the solution conductivity 
and relative volatility, volatility of the solvent, surface tension, and dielectric con-
stant. The process parameters refer to the flow rate, the applied voltage, the needle 
diameter, the distance between the tip of the needle and collector, and the geometry 
of the collector. The environmental conditions include the relative humidity and 
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temperature [1, 4, 7, 8, 18]. The solution properties and the process parameters 
have predominant influence on the formation and morphology of the produced 
nanofibers, while the environmental conditions do not have a significant effect [1]. 
Moreover, all these factors are responsible for a flawless electrospinning process, 
which leads in the formation of the desirable electrospun nanofibers with the 
requisite characteristics [8]. Consequently, the careful monitoring of these factors 
can ensure the formation of smooth, highly porous nanofibers without beads [4, 8].
2.3.1 Effects of polymer concentration
The electrospinning method relies on the creation of electric charges in the 
polymer solution, which generate a charged jet [4]. When the polymer concentra-
tion is low, then the entangled polymer chains break into fragments before reaching 
the collector, due to the applied electric field and surface tension [4, 9, 12]. The 
entanglement of the polymer is necessary for fiber formation, but in the state of 
low polymer concentration. In this state, the phenomenon of electrospraying will 
take place and particles, instead of fibers, are formed [8, 19]. It has been reported 
that the boundary concentration between electrospray and electrospinning is 
solvent-dependent [8, 20]. Moreover, these polymer fragments cause the formation 
of nanofibers with beads [4]. In turn, if the polymer concentration increases, the 
Table 1. 
Parameters that affect the electrospinning technique.
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chain entanglement among polymer chains will increase because of the increase 
in solution viscosity. As a result, these chain entanglements overcome the surface 
tension and uniform electrospun nanofibers devoid of beads are formed [4, 21]. If 
the concentration increases beyond a critical value, then the flow of the jet will be 
blocked as the droplet will dry out at the tip of the metallic needle, and the polymer 
jet would not be initiated. In this case, the clog should be removed to let the electro-
spinning process continue [4, 12, 18] and obtain beadles nanofibers with increased 
diameter [1, 4, 18, 22, 23].
2.3.2 Effects of polymer viscosity
With respect to the electrospinning method, the polymer viscosity is included 
in the solution properties. It has been reported that a change in polymer viscosity 
can affect the morphologies of the beads in nanofibers [4, 24]. If the viscosity of the 
polymer solution is low, the shape of the produced nanofibers will be round droplet 
like, but if the viscosity of the polymer solution is sufficient, then stretched droplet 
or eclipsed shapes fibers will be formed [4, 22–25]. Moreover, an increase in poly-
mer concentration causes increase in polymer viscosity, and as a result, an increase 
beyond a critical value will block the flow of the jet and the droplet will dry out at 
the tip of the metallic needle. In conclusion, the determination of the critical value 
of viscosity is essential, as an increase in the polymer viscosity leads to thicker and 
bead-free nanofibers with increased diameter [4, 21]. Conversely, if the increase of 
viscosity is too high, beads will be generated in the nanofibers [1, 7].
2.3.3 Effects of solution conductivity
The solution conductivity is another solution parameter, which affects the elec-
trospinning process and as a result the formation of nanofibers and their diameter 
distribution [7, 8]. The solution conductivity has a significant role on the formation 
of the Taylor cone and in controlling the diameter of the nanofibers [4, 8]. Poor 
conductivity solutions are not capable of producing electrospinning results, as the 
surface of the droplet will have no charge to form the Taylor cone. Conversely, an 
increase in the solution conductivity will lead to the Taylor cone formation because 
of the increase of the charge on the surface of the droplet. This will also lead to the 
reduction of the fiber diameter [4, 8, 26]. It has been reported that if the solution 
conductivity increases beyond a critical value, the formation of the Taylor cone will 
be prevented. This can be attributed to the Coulombic forces between the charges 
on the surface of the fluid and the force due to the external electric field [4]. It has 
been well documented that a highly conductive polymer solution is unstable and 
leads to a wide diameter distribution when a strong electric field is applied [4, 7, 27]. 
However, the polymer solution conductivity could be adjusted by the addition of 
a suitable salt [4, 7]. The addition of the salt affects the electrospinning process by 
increasing the number of the ions in the polymer solution resulting in the increase 
of surface charge density of the fluid and the electrostatic force produced by the 
applied electric field [4, 7, 22, 28, 29]. Moreover, the addition of the salt increases 
the polymer solution conductivity resulting in the reduction in the tangential elec-
tric field along the surface of the fluid [4]. Concluding, the increase of the solution 
conductivity leads to ultrafine nanofibers with reduced diameter [1, 7, 8, 26].
2.3.4 Effects of surface tension
The surface tension is included in the solution parameters, which affect the 
electrospinning process and the nanofiber morphology, but there is no conclusive 
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correlation [1]. Nevertheless, it has been reported that there is a delicate balance 
between the surface tension and the electric field (conductivity, concentration, 
and viscosity), which affects the ultimate morphology of the nanofibers [4, 7]. 
Particularly, the surface tension and the applied electric field cause the disentan-
gling and breaking of the perplexed polymer chains into fragments before reach-
ing the collector, which cause the formation of beads in the nanofibers [4, 9, 12]. 
Another case refers that the surface tension influences the surface of the polymeric 
nanofibers, and in the case of poor conductivity of polymers, charges accumulate 
onto the surface and as a result, beaded formation is prompted [7].
2.3.5 Effects of molecular weight of polymer
The molecular weight of the polymer is included in the solution properties, and 
it is a parameter that affects the viscosity of the solution. Ordinarily, an increase in 
molecular weight, until a critical value, leads to increase in solution viscosity and 
the formation of nanofibers with fewer beads [1, 7]. In general, polymers with high 
molecular weight are preferred as they cause extensive chain entanglement, which 
facilitates the nanofiber formation during the spinning process. On the contrary, 
polymer solutions with lower molecular weight may lead to the formation of beads 
or break up into droplets [30]. Overall, the molecular weight is one of the most 
important parameters, which affect the outcome nanofibers and as a result the 
electrospinning process.
2.3.6 Effects of solvent volatility
The solvent volatility is another parameter of solution parameters, which affects 
the electrospinning process and as a result the formation of smooth and beadles 
electrospun nanofibers. The solvents that are preferred in the electrospinning 
process should be polymers that are entirely soluble, and they should have moder-
ate (appropriate) boiling point, which is related with the volatility of the solvent 
[4, 8]. Common volatile solvents, with high evaporation rates, which ensure the 
facile evaporation of the solvent from the tip of the needle to collector, are used in 
the electrospinning process [4]. The rate of solvent evaporation from the polymer 
solution jet leads to phase separation and creation of secondary structures on fibers 
[4, 7, 31]. It has been reported that highly volatile solvents absorb the heat from the 
jet, thus lowering the temperature of the liquid jet; this temperature drop decreases 
the thermodynamic stability of the nonsolvent phase. These phenomena result in 
high evaporation rates, which cause the drying of the jet at the tip of the needle, 
block the needle tip, and hence hinder the electrospinning process or else the early 
solidification of the polymer jet. Overall, highly volatile solvents are avoided in the 
electrospinning process because fiber formation will not be completed [4, 7, 8]. 
Similarly, solvents with low volatility should not be used, because they have high 
boiling points, which prevent the drying during the nanofiber jet formation or else 
the solidification process could be retarded because the solvent evaporation is low 
[4, 8]. Conclusively, the type of the solvent and especially their volatility profile, 
and the rate of evaporation are very important parameters for the formation of 
nanofibers. It is cited that higher volatility demands and higher flow rates result in 
the formation of electrospun nanofibers with fewer beads [1, 4, 7].
2.3.7 Effects of solution volatility
Relative volatility is a measure of the differences in volatility between two 
components and is used in the design of separation or absorption processes. The 
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solution relative volatility is a solution parameter that has similar effect with the 
volatility of the solvent. Solutions that are prepared from solvents of very low 
volatility may deliver wet and cross-linked nanofibers or even no nanofibers, at all 
[4, 8, 30]. Conversely, the usage of highly volatile solvents for the solution prepara-
tion may result in intermittent spinning because of the solidification of the polymer 
jet at the tip of the needle [4, 7, 30]. It has been reported that an increase in relative 
volatility of polymer solution causes the appearance of porous microstructure due 
to higher volatility, and this affects fiber’s porosity and morphology [7].
2.3.8 Effects of dielectric constant
The dielectric constant, sometimes called relative permittivity or specific induc-
tive capacity, is the ratio of the permittivity of a substance to the permittivity of 
free space. It is an expression of the extent to which a material concentrates electric 
flux. The dielectric constant of the solvent(s), used in the successful electrospin-
ning and the formation of electrospun nanofibers, has to be sufficient, but not high 
[1]. It has been reported that an increase in the dielectric constant of the solution 
leads to an increase of the number of jets. On the contrary, a reduction in the value 
of the dielectric constant to a single digit leads to the formation of a single jet. 
Furthermore, the value of the solution dielectric constant may influence the stabil-
ity of the jet, as bending instability may be reduced with a lower charge density 
resulting in a longer and stable jet [30]. Overall, the solution dielectric constant has 
to be sufficient for the successful electrospinning and the formation of electrospun 
nanofibers [1].
2.3.9 Effects of flow rate
The flow rate is an important parameter belonging to the process parameters, 
which influences the diameter of the electrospun fibers and subsequently the 
charge density and the morphology of the nanofibers [4, 7]. It is reported that there 
is a critical point depending on the polymeric solution, in which the critical flow 
rate leads to the formation of uniform electrospun nanofibers [4, 8]. In the case of 
increasing the flow rate, beyond the critical value, nanofibers with larger diameter 
and pore size are produced and the formation of beaded structures is enhanced 
[4, 7, 8, 18, 31]. This bead formation is caused due to the incomplete drying of the 
polymeric jet. When the delivery rate of the polymeric jet to the needle tip exceeds 
the rate at which the polymeric solution is removed from the tip by the electric force 
in the metallic collector, a mass balance shift results, which leads to a sustained but 
unstable jet and bead formation [4, 7, 32]. In the case of decreasing the flow rate, 
beyond the critical value, smooth, fine, and thinner nanofibers are formed [1, 18]. 
It is cited that increases and decreases in the flow rate affect the nanofiber forma-
tion, and as a result, a minimum flow rate of the polymeric solution is preferred 
in order to replace the solution that is lost with a new one, during jet formation, as 
the solution will have enough time for polarization, stretching, and drying [4, 31]. 
Overall, lowering the flow rate causes the formation of thinner nanofibers instead 
of too high flow rates in which the nanofiber diameter increases and the continuity 
of the fiber interrupts bead formation [1, 7].
2.3.10 Effects of applied voltage
The applied voltage is an important process parameter, which affects the 
strength of the electric field and therefore influences the diameter and the nanofi-
ber morphology [7, 8]. Moreover, an increase in the applied voltage causes a change 
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in the shape of the Taylor cone, and as a result, a critical voltage, which depends on 
the polymeric solution, is needed for the formation of ultrafine nanofibers given a 
certain distance between the needle tip and collector [4, 5, 7, 8]. An increase in the 
applied voltage leads to the formation of thinner nanofibers because of the stretch-
ing of the polymer solution in correlation with the charge repulsion within the 
polymer jet [1, 4, 7, 18, 33]. A higher applied voltage, above the critical value, may 
lead to an irregular increase of the diameter and the formation of beaded, nonuni-
formity nanofibers [4, 7, 8, 22]. This situation is attributed to the decrease in the size 
of the Taylor cone and increase in the jet velocity, keeping the same flow rate  
[4, 22, 34]. However, there are studies that have shown that the increase in the 
applied voltage leads to increase in the diameter of the nanofibers [4, 18, 21]. This 
phenomenon may be explained as the increase of the voltage leads to the decrease 
of the volume of the drop at the tip of the needle causing the receding of the 
Taylor cone resulting in increase in the jet length and fiber diameter because of the 
increase in the amount of the ejected fluid and the flow rate of polymer solution  
[4, 18, 21]. In conclusion, in general, the increase of the applied voltage, until a 
critical value, causes the formation of thinner nanofibers, but this depends on the 
type of the polymeric solvent [1, 4, 7, 8, 18]. It is worth mentioning that the problem 
of bead formation was not solved by varying the applied voltage [18].
2.3.11 Effects of needle tip to collector distance
The distance between the metallic needle tip and the collector could be easily 
affecting the morphology of nanofibers because it is dependent on the deposi-
tion time, evaporation rate, and the whipping or instability interval [4, 7, 8, 35]. 
Therefore, a critical distance is needed to be fixed for the preparation of dry, 
smooth, and uniform electrospun nanofibers [1, 4]. A decrease in the distance 
between the tip and the collector leads to the enlargement of diameter of nanofibers 
and the generation of beads, while an increase in this distance leads to the formation 
of nanofibers with decreased diameter [1, 7, 8, 21, 35]. However, there are cases that 
the morphology of nanofibers is not affected by the distance between the metallic 
needle and the collector [4, 32]. Increasing the distance between the needle tip and 
the collector, the nanofiber diameter decreases and there is a minimum distance 
required to obtain dry, smooth, and uniform electrospun nanofibers, but when the 
distance is too short or too large, beads are formed [1, 7].
2.3.12 Effects of relative humidity
The relative humidity is a factor belonging to the environmental conditions 
of the electrospinning, which affects the diameter and the morphology of the 
electrospun nanofibers [4, 8, 36, 37]. The relative humidity is crucial for the pro-
duction of ultrafine nanofibers with acceptable morphology, because it affects the 
formation of pores on the fiber surface via solvent evaporation or else controlling 
the solidification process of the charged jet [4, 7, 8]. The appropriate amount of 
the relative humidity depends on the chemical nature of the used polymer. A high 
relative humidity suppresses the evaporation rate as long as the surface area of the 
jet increases and the charge per unit area on the surface of the jet decreases resulting 
in the capillary instability and the beaded structure formation [1, 7, 8]. It has been 
cited that humidity controls the evaporation rate of the fluid jet when the water is 
used as a solvent component [7]. Overall, lower relative humidity enables higher 
flow rate, and as a result, the formation of beads is reduced, while higher relative 
humidity leads to the appearance of porous microstructures due to evaporation 
effects and/or phase separation [1, 7, 8].
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2.3.13 Effects of temperature
The temperature is another factor belonging to the environmental conditions of 
the electrospinning, which is crucial for the production of ultrafine nanofibers with 
acceptable morphology, because it affects the diameter of the fibers [4, 8, 36, 37]. 
Moreover, temperature causes changes in the average diameter of the nanofibers 
resulting in modification of the electrospun nanofibers size by causing two oppos-
ing effects; first, it increases the evaporation rate of the solvent and secondly, it 
decreases the viscosity of the polymer solution. These effects have the behavior of 
two opposite mechanisms, but both of them lead to a mean fiber diameter decrease 
[4, 8]. In general, an increase in the temperature leads to thinner nanofibers forma-
tion [1, 4, 8].
3. Electrospinning in per oral drug delivery
With the appearance of nanotechnology, researchers have become more 
attracted in studying the characteristic properties of nanoscale materials. 
Electrospinning, a method of electrostatic fiber fabrication, has established more 
attention in recent years due to its usefulness and potential for applications in 
diverse fields, like tissue engineering, biosensors, filtration, wound dressings, drug 
delivery, and enzyme immobilization. The nanoscale fibers are generated by the 
application of strong electric fields on polymer solution and mimic better the extra-
cellular matrix components as compared to the conventional techniques, offering 
various advantages, like high surface area to volume ratio, tunable porosity, and the 
ability to manipulate nanofiber composition in order to get desired properties and 
function [38]. The use of electrospun nanofibers, as formulation systems for oral 
drug delivery, has been studied extensively over the past decades in fast/immediate 
release systems and more recently in modified release systems.
Numerous researchers have been studying orodispersible or fast-dissolving 
drug delivery formulations produced from nanofiber-loaded systems that rapidly 
disintegrate in the oral cavity due to nanofibers’ large surface area, which causes 
immediate disintegration in water solutions and fast drug release [18, 39–46]. 
Applications of the electrospinning technique on modified per oral drug delivery 
are summarized in Table 2.
3.1 Electrospinning in controlled per oral drug delivery
Oral controlled drug release systems are characteristic in formulation, and 
researchers have developed electrospun nanofibers for usage in treatment and 
management of disorders that need special drug release patterns. Scientists have 
developed amyloid-like bovine serum albumin with ampicillin sodium salt nanofi-
bers by electrospinning, and the in vitro results showed controlled release behavior 
[47]. Electrospun fiber mats were also investigated as drug delivery systems using 
tetracycline hydrochloride as a model drug. The nanofibers were made either from 
poly(lactic acid), poly(ethylene-co-vinyl acetate), or from a 50:50 blend of the 
two. The release of the tetracycline hydrochloride from these new drug delivery 
systems followed controlled release behavior [48]. Moreover, polyvinyl alcohol 
nanofibers loaded with curcumin or its β-cyclodextrin inclusion complexes were 
prepared using an electrospinning process. In vitro dissolution tests showed that the 
drug release profiles of polyvinyl alcohol/curcumin and polyvinyl alcohol/complex 
fibers were different, with release from the latter occurring more rapidly [49]. In 
addition, electrospun gelatin nanofibers were prepared by sequential crosslinking 
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using piperine as a hydrophobic model drug by sandwiching the drug-loaded 
gelatin nanofiber mesh with another gelatin nanofiber matrix without drug (act-
ing as diffusion barrier). The results indicated controlled and sustainable release 
of the drug for prolonged time [50]. Researchers have also prepared melatonin-
loaded nanofibrous systems based on cellulose acetate, polyvinylpyrrolidone, and 
hydroxypropylmethylcellulose. The electrospun nanofiber mats that were inserted 
Table 2. 
An overview of the electrospinning technique applications in modified per oral drug delivery.
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in hard gelatin capsules exhibited variable release profiles in the gastric-like flu-
ids, ranging from 30 to 120 min, while the electrospun nanofiber mats that were 
inserted in DRcaps™ capsules released melatonin at a slower pace [51]. In another 
study, nanofibers of cellulose acetate and polyvinylpyrrolidone loaded with mela-
tonin were prepared and compressed at various pressures into monolayered tablets. 
The nanofiber mats were then incorporated into three-layered tablets, containing in 
the upper and lower layer combinations of lactose monohydrate and hydroxypro-
pylmethylcellulose, as modifying accessories, and their in vitro dissolution profiles 
have showed promising results in modified per oral drug delivery [52].
3.2 Electrospinning in delayed per oral drug delivery
Besides controlled drug release, researchers have investigated electrospun 
nanofibers as oral delivery systems for delayed release systems. In a study, both 
fast dissolving and sustained release drug delivery systems comprising mebeverine 
hydrochloride embedded in either povidone K60 or Eudragit RL 100–55 nanofibers 
have been prepared by electrospinning. The in vitro dissolution tests of the povidone 
K60 fiber mats revealed dissolution within 10 s, while the Eudragit fibers revealed 
pH-dependent drug release profiles, with only very limited release at pH 2.0, but 
sustained release over approximately 8 h at pH 6.8. As a result, it can be stated that 
the Eudragit nanofibers have the potential to be developed as oral drug delivery 
systems for localized drug release in the intestinal tract, whereas the povidone mate-
rials may find application as buccal delivery systems or suppositories [53]. Various 
researchers have synthesized gelatin nanofibers by electrospinning, using piperine 
as a hydrophobic model drug. The electrospun gelatin nanofibers were cross-linked 
by exposing to saturated glutaraldehyde vapor, to improve their water-resistive 
properties. The results illustrated good compatibility of the hydrophobic drug in 
gelatin nanofibers with promising controlled drug release patterns by varying cross-
linking time and the pH of the release medium [54]. In another scientific report, 
a solvent-based electrospinning method was used to prepare nanofiber-based 
capsules including drugs (uranine was used as a water-soluble drug and nifedipine 
as a water-insoluble drug) for controlled release delivery systems using methacrylic 
acid copolymer as a polymer. The in vitro release of uranine or nifedipine from the 
nanofiber-packed capsules and milled powder of nanofiber-packed capsules showed 
controlled release of uranine or nifedipine, as compared to capsules of a physical 
mixture of methacrylic acid copolymer and each drug. The in vivo pharmacoki-
netic evaluation in rats, after intraduodenal administration of nanofiber-packed 
capsules or milled powder of nanofiber-packed capsules including uranine and/or 
nifedipine, clearly demonstrated that the application of the nanofibrotic technique, 
as a drug delivery system, offers drastic changes in pharmacokinetic profiles for 
both water-soluble and water-insoluble drugs [55]. Furthermore, nanofibers made 
from methacrylic acid copolymer S, containing acetaminophen, were prepared 
using a solvent-based electrospinning method. The in vitro dissolution rate profiles 
of acetaminophen showed that the tablets based on methacrylic acid copolymer S 
nanofibers did not disintegrate in the intestine in the lower pH region and could 
regulate the drug release in a pH-dependent manner [56].
3.3 Electrospinning in colon-targeted per oral drug delivery
In addition to the previously described drug delivery systems, many scientists 
have demonstrated that the electrospinning method could be regarded as a modern 
approach for the preparation of colon drug delivery systems leading to market-
able products. Eudragit L 100-55 nanofibers loaded with diclofenac sodium were 
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successfully prepared using an electrospinning process. In vitro dissolution tests veri-
fied that all the drug-loaded Eudragit L 100-55 nanofibers had pH-dependent drug 
release profiles, with limited release at pH 1.0, but a sustained and complete release 
at pH 6.8, indicating the potential of oral colon-targeted drug delivery systems 
development [57]. Researchers prepared medicated shellac nanofibers providing 
colon-specific sustained release of ferulic acid using coaxial electrospinning. The 
in vitro dissolution tests demonstrated that there was minimal ferulic acid release at 
pH 2.0, and sustained release in a neutral dissolution medium [58]. Another group 
of researchers have prepared electrospun nanofibers of indomethacin aimed for 
colon delivery using Eudragit S and Eudragit RS as polymers. It was shown that the 
ratio of drug:polymer and polymer:polymer were pivotal factors to control the drug 
release from nanofibers. A formulation containing Eudragit S:Eudragit RS (60:40) 
and drug:polymer ratio of 3:5 exhibited the most appropriate drug release, as a colon 
delivery system with a minor release at pH 1.2, 6.4, and 6.8 and a major release at pH 
7.4 [59]. Electrospun nanofibers were also successfully prepared using indomethacin 
as a drug and Eudragit RS100 and S100 as polymers for colonic drug delivery [60]. 
Moreover, celecoxib-loaded electrospun nanofibers were developed using a com-
bination of time-dependent polymers with pectin to achieve colon-specific drug 
delivery systems. The drug release was limited in the acidic media; while, in the 
simulated colonic media, it was higher from formulations containing the excipient 
pectin [61]. Likewise, electrospun fibers loaded with budesonide were prepared with 
the aim of controlling its release in the gastrointestinal tract using Eudragit RS 100, a 
polymer soluble at pH > 7, commonly used for enteric release of drugs. The dissolu-
tion rate measurements using a pH-change method showed low drug dissolution at 
pH 1.0 and sustained release at pH 7.2, representing an effective method for drug 
targeting to terminal ileum and colon with the aim of improving the local efficacy of 
budesonide for the treatment of some inflammatory bowel diseases [62]. Researchers 
have developed a novel core-shell-structured nanofilm for colon delivery by coaxial 
electrospinning using bovine serum albumin as protein model. First, the protein-
loaded chitosan nanoparticle was prepared by ionic gelation, and then, the coaxial 
nanofilm was fabricated using alginate as shell layer and the protein-loaded chitosan 
nanoparticle as core layer. The protein release in different simulated digestive fluids 
revealed that the electrospun nanofilm is a promising colon-specific delivery system 
for bioactive proteins [63]. Another group of scientists reported in their work that 
the pH-responsive drug delivery systems could mediate drug releasing rate by chang-
ing the pH values at specific times as per the pathophysiological need of the disease. 
Their study demonstrated that a mussel-inspired protein polydopamine coating 
can tune the loading and releasing rate of charged molecules from electrospun 
poly(ε-caprolactone) nanofibers in solutions with different pH values. The in vitro 
release profiles showed that the positively charged molecules led to a significantly 
faster release in acidic than in neutral and basic media, while the results of special-
ized assays showed that the media containing doxorubicin released in solutions at 
low pH values could kill a significantly higher number of cells than those released 
in solutions at higher pH values. The pH-responsive drug delivery systems based on 
polydopamine-coated poly(e-caprolactone) nanofibers could have potential applica-
tion in the oral delivery of anticancer drugs for treating gastric cancer and in vaginal 
delivery of antiviral or anti-inflammatory drugs, which could raise their efficacy, 
deliver them to the specific site, and minimize their toxicity [64].
3.4 Electrospinning in biphasic and dual per oral drug delivery
More to the point of modified drug delivery systems, researchers have designed 
and fabricated nanostructures using electrospinning for providing biphasic drug 
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release profiles. A research work investigated the biphasic release profile of keto-
profen of core/sheath nanofibers prepared using as polymers polyvinylpyrrolidone 
for the sheath and ethyl cellulose for the core matrix by coaxial electrospinning. 
The in vitro dissolution tests showed that the nanofibers produced could provide 
a biphasic drug release profile consisting of an immediate and a sustained release 
[65]. In another work, core-sheath nanofibers were also prepared using ketoprofen 
as a model drug, and polyvinylpyrrolidone and zein as the sheath polymer and core 
matrix excipient, respectively, by coaxial electrospinning. The in vitro dissolution 
tests showed that the nanofibers could provide an immediate release of 42.3% of the 
drug followed by a sustained release over 10 h of the remaining drug [66]. Other 
researchers have used simple sequential electrospinning to create a triple layered 
nanofiber mesh with biphasic drug release behavior. The mesh was composed of 
zein and polyvinylpyrrolidone as the top/bottom and middle layers, respectively. 
Ketoprofen was used as a model drug, and polyvinylpyrrolidone was blended with 
graphene oxide to improve the drug release functionality of the nanofiber as well 
as its mechanical properties. The in vitro release tests demonstrated time-regulated 
biphasic drug release [67]. In another study, gelatin-ciprofloxacin nanofibers 
containing various amounts of ciprofloxacin were fabricated on the surface of 
Mg-Ca alloy via an electrospinning process. Prolonged drug release was attained 
from gelatin-ciprofloxacin nanofibers coating along with initial rapid drug release 
of around 20–22% during 12 h, followed by a slow release stage that can effectively 
control the infection [68]. Moreover, resveratrol (a promising natural substance 
for periodontal disease treatment due to its anti-inflammatory and antioxida-
tive effects) was successfully incorporated into polycaprolactone-nanofibers and 
enabled a biphasic-release kinetic pattern [69]. In a recent study, it was demon-
strated that the production of core-shell fibers via modified coaxial electrospinning 
achieved controlled release of ampicillin-loaded polycaprolactone nanofibers 
covered by a polycaprolactone shield. The in vitro release studies showed that the 
drug release kinetics of core-shell products is closer to zero-order kinetics, while the 
drug release kinetics of single electrospinning of the core resulted with burst release 
[70]. Scientists have also used piroxicam as a low-dose, poorly soluble drug and 
hydroxypropyl methylcellulose as an amorphous-state stabilizing carrier polymer in 
nanofibers to produce biphasic-release drug delivery systems [71].
Dual drug delivery systems have also been successfully developed by researchers. 
In a recent study, aceclofenac/pantoprazole-loaded zein/Eudragit S 100 nanofibers 
were developed using a single nozzle electrospinning process. The in vitro release 
studies ensured the efficiency of the nanofibers in sustaining the release of both 
drugs up to 8 h, while the in vivo experiments confirmed that the co-administration 
of pantoprazole and aceclofenac reduced the gastrointestinal toxicity induced by 
nonsteroidal anti-inflammatory drugs [72].
4. Conclusions
The fabrication of electrospun ultrafine fiber meshes from biodegradable 
and biocompatible polymers has opened new horizons in the biomedical field. 
Electrospinning, being a simple, highly versatile, and robust technique for the 
production of fibers with diameters from submicron down to nanometer scale, 
could provide a useful method for the development of novel drug carriers capable of 
affecting the drugs’ modified release. By careful selection of polymers, it is now pos-
sible to deliver drugs, with diverse stereoelectronic and physicochemical properties, 
in a required manner using electrospun nanofibers. Mutatis mutandis, in order to 
make further progress in the drug delivery field, it is necessary to identify ways that 
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will allow fabrication of nanofibers with the desired morphological and mechanical 
properties in a reproducible manner. Thus, organic solvent mixtures, drug content, 
and electrospinning parameters, which will influence nanofiber properties, such as 
morphology, applicability, and quality, are currently under intense investigation.
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